Valuation: Sanofi

Market Cap 90.95B 104B 83.82B 77.69B 147B 9,864B 150B 1,005B 391B 4,868B 390B 382B 16,827B P/E 2026 *
11.4x
P/E 2027 * 10.5x
Enterprise Value 101B 115B 92.77B 85.99B 163B 10,917B 166B 1,112B 433B 5,388B 432B 423B 18,623B EV / Sales 2026 *
2.13x
EV / Sales 2027 * 1.92x
Free-Float
89%
Yield 2026 *
5.61%
Yield 2027 * 5.95%
1 day+0.44%
1 week+0.32%
Current month+0.72%
1 month-3.14%
3 months-7.90%
6 months-7.91%
Current year-8.66%
1 week 73.07
Extreme 73.07
76.96
1 month 71.65
Extreme 71.65
77.64
Current year 71.65
Extreme 71.65
84.73
1 year 71.65
Extreme 71.65
90.66
3 years 71.65
Extreme 71.65
110.34
5 years 71.65
Extreme 71.65
110.34
10 years 63.18
Extreme 63.18
110.34
Manager TitleAgeSince
Chief Executive Officer 65 2026-04-30
Director of Finance/CFO 64 2024-03-31
Chief Tech/Sci/R&D Officer 51 2023-09-10
Director TitleAgeSince
Director/Board Member 60 2019-04-29
Director/Board Member 57 2020-04-27
Director/Board Member 64 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.44%+0.32% - - 104B
+2.96%+3.01%+59.87%+173.31% 1,102B
+3.05%+5.23%+72.11%+67.81% 643B
-0.04%+1.20%+35.72%+87.93% 450B
-2.58%-2.07%+27.62%+22.57% 336B
+1.36%+0.17%+29.90%+49.33% 288B
+1.98%+4.08%-25.78%-39.02% 222B
+0.45%+1.65%+25.65%+68.35% 199B
+5.21%+7.93%+21.99%+83.23% 169B
+1.48%-0.04%-4.64%-32.25% 137B
Average +0.81%+2.00%+26.94%+53.47% 393.9B
Weighted average by Cap. +1.48%+1.86%+41.96%+87.59%

Financials

2026 *2027 *
Net sales 47.19B 53.92B 43.49B 40.31B 76.52B 5,118B 77.75B 521B 203B 2,526B 202B 198B 8,730B 50.26B 57.43B 46.32B 42.93B 81.49B 5,450B 82.81B 555B 216B 2,690B 216B 211B 9,297B
Net income 7.8B 8.91B 7.18B 6.66B 12.64B 845B 12.84B 86.15B 33.5B 417B 33.44B 32.72B 1,442B 8.62B 9.85B 7.95B 7.37B 13.98B 935B 14.21B 95.29B 37.06B 462B 37B 36.19B 1,595B
Net Debt 9.71B 11.1B 8.95B 8.29B 15.74B 1,053B 16B 107B 41.73B 520B 41.66B 40.75B 1,796B 5.64B 6.44B 5.19B 4.81B 9.14B 611B 9.29B 62.28B 24.22B 302B 24.18B 23.65B 1,043B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
26-07-07 €76.02 +2.05% 126
26-07-06 €74.49 -1.73% 641
26-07-03 €75.80 +0.44% 52
26-07-02 €75.47 +3.28% 47
26-07-01 €73.07 -2.91% 477
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
75.78EUR
Average target price
96.49EUR
Spread / Average Target
+27.33%

Quarterly revenue - Rate of surprise